Arkolith/Insider Trading/ONC/Form 4

Oyler John

Chief Executive Officer, DirectorBeOne Medicines Ltd. (ONC) · full profile →Form 4 · filed Jun 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$501K
Net Open-Market Flow
-$501K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Grant(A)178K—$05.7M
Jun 11, 2026Sell(S)741$256.23$190K1K
Jun 11, 2026Sell(S)859$257.59$221K349
Jun 11, 2026Sell(S)200$258.28$52K149
Jun 11, 2026Sell(S)149$258.81$39K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 11, 2026Grant(A)345K—$0345K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001042047-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML